chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles/ two people who have same side effect as hers; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HERPES ZOSTER (non-serious), outcome "unknown", described as "shingles/ two people who have same side effect as hers".  Additional Information: Other Products: Not Provided. Patient History: Not Provided. Patient contacted VAERS in September that stated they send it to the manufacturer and caller states it has been 75 days since reported it and patient was wondering if the report was going to the cloud and nobody looks at it? Caller would like to know if the information reported to VAERS is transmitted to Pfizer? Caller states she cannot find any reports of the side effect she had but she personally knows two people in a town of 6000 people that had this side effect. Patient had shingles and knows multiple people who developed shingles after getting the second vaccine or booster and it is only reported in withheld by their government. Patient states Shingles was worse than having Covid. Caller states withheld gave her the vaccine and they will not report anything. Caller states her HCP did not know stuff and mentions her HCP dismissed her as there was no reports of this adverse effect from Pfizer meanwhile many HCPs have seen this. Caller states her HCP was very dismissive when she suggested there was correlation between Shingles and the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101797217 same reporter drug AE, different patient;US-PFIZER INC-202101797783 same reporter drug AE, different patient
2 shots of Moderna + Pfizer booster; 2 shots of Moderna + Pfizer booster; have gotten Covid; have gotten Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna vaccine (dose 1), for COVID-19 immunization; Moderna vaccine (dose 2), for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "2 shots of Moderna + Pfizer booster"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "have gotten Covid". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Clinical course: The patient mentioned that it got him, despite 2 shots of Moderna and Pfizer booster-last Wednesday he tested positive for Covid. Symptoms minimal-mostly scratchy throat that disappeared in hours-never any fever or loss of taste. He was isolating and wears mask.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Severe headache, body aches, fever, severe light sensitivity, joint pain, muscle pain, blepharitis, keratoconjunctivitis, nausea, vision disturbance. Fever lasted 4-5 days, other symptoms persisted for over 2 months.
Symptoms started about 45 hours after injection. Fever up to 103, vomiting, dizzy, no energy, severe sweating. Still ill on Tuesday, November 2nd. (almost 5 days since injection)
Headache and interstitial pain starting the evening of dose 2 injection, generalized  body aches, joint pain (hips, shoulders, metacarpal/phalange, knees) starting shortly after midnight after injection for about 28hrs. Day 2 post injection significant brain fog through 48hrs post injection. Day 3 fog lifting gone by about 72 hrs post injection. Increased thirst throughout.
Hurts when she breathes; Unable to lift arm; On and off chest pain; Spasms; Fast heartbeat; Did not feel good; Headache; Vomiting; A spontaneous report was received from a consumer regarding a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273), and experienced the events, did not feel good, headache, vomiting, chest pain, spasms, a fast heartbeat, unable to lift arm, and hurts when she breathes.  The patient's medical history was not provided. Concomitant medications were not provided by the reporter.   On 09 Jan 2021, approximately 24 hours prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 10 Jan 2021, the patient did not feel well and experienced a headache and vomiting.   On 11 Jan 2021, the patient experienced on and off chest pain, spasms, and a fast heart beat. She was unable to lift her arm and it hurt when she would breathe. An emergency medical technician (EMT) was called to assist the patient. No further details were provided. Treatment for the events was not provided.   Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events, did not feel good, headache, vomiting, chest pain, spasms, a fast heartbeat, unable to lift arm, and hurts when she breathes, was not reported.; Reporter's Comments: This case concerns a female patient, who experienced serious unexpected events of painful breathing, and non-serious unexpected event of vaccination site movement impairment, chest pain, muscle spasm, malaise, and heart rate increased; and non-serious expected events of headache and vomiting. The event of malaise, headache and vomiting occurred 2 days after mRNA-1273 (lot # unknown) administration. The event of painful breathing, vaccination site movement impairment, chest pain, muscle spasms, heart rate increased, occurred day 3 after mRNA-1273 (lot # unknown) administration. Treatment details were not provided. Very limited information regarding this event has been provided at this time.  Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
10 minutes after vaccine administration, pt developed 2 hives approx 5 mm, 1 on each dorsum of foot with minimal redness and mild swelling of hive.  Lungs clear.  Remained awake and alert.
No further AE; temperature excursion; This spontaneous report was received from a practice manager and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 16-SEP-2020, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 injection, lot # R025726, expiration date: 26-MAY-2021 (injection site and route of administration were not provided) for prophylaxis.  On 04-AUG-2020, the administered dose experienced the temperature excursions of below 2 degrees Celsius (C) (1.1 C) for 27 hours and 45 minutes and above 9 degrees Celsius (9 C) for 1 hour and 15 minutes. The digital data logger was involved. No previous temperature excursion had occurred. No further adverse events (AE) were reported.  This is one of multiple reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: R025726; expirationdate: 26-MAY-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2010USA001083:Same Reporter
Increased signs of PMS, off schedule. The Nexplanon makes them mild and I don't have a period, but still get PMS-ish symptoms such as mood swings, increased arousal, sensitive breasts, increased hunger, increased tiredness. I got all of those just two days after receiving the first dose of the Moderna COVID vaccine, but they weren't due until later this month, and they were worse than usual. It's a mild thing, and has subsided, but with the J&J throwing clots on some women who are likely on birth control, I thought it was worth mentioning. Thank you for your time!
Initial misuse report received from healthcare professional on 20 Aug 2014. A patient (age and sex not reported) had received an expired dose of FLUZONE (expiry date: 14 Apr 2014) (dose, lot number, dose number and site of vaccination not reported) on an unspecified date. At the time of this report, the patient did not experience any adverse events. Documents held by sender: None.
A few hours after receiving vaccine mom noticed Right arm and Right leg seizure and tremors pursue Paramedics arrived gave IM Benadryl Patient taken to ER given PO Benadryl with resolution.
Information was received on 09-OCT-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient was inoculated with a dose of ZOSTAVAX vaccine on or about 18-AUG-2014, at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 30-JUN-2016, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune systems, which was diagnosed as herpes zoster, or shingles. On or about the dates of 14-JUL-2016, 20-SEP-2016 and 08-NOV-2016, the patient sought subsequent treatment from her physician for ongoing and worsening outbreaks of shingles and excruciating accompanying pain. The patient was been prescribed VALTREX for management of her painful condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Symptoms of type 1 diabetes; Sickest ever been; This spontaneous case was received on 12-Oct-2020 from other non-health professional via Novartis (reference number: NUS2019US228530) and concerned patient of an unknown age and gender.  The patient's medical history and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with influenza virus vaccine polyvalent (brand not specified, dose, anatomical location, route of administration and indication: not reported). The batch number was not reported.   On an unknown date, ten days after receiving influenza virus vaccine polyvalent, the patient was sickest than ever been.  On an unknown date, another ten days after receiving influenza virus vaccine polyvalent symptoms of type 1 diabetes showed up immediately.  The outcome of the events was not reported.   The reporter did not provide a causality assessment.  The event of 'Type 1 diabetes mellitus' was considered to be medically significant by a Physician within Risk Management Department.  Company comment: A patient of an unknown age and gender was administered influenza virus vaccine polyvalent. The patient developed malaise, ten days after receiving vaccine. Another ten days after receiving influenza virus vaccine polyvalent symptoms of type 1 diabetes. The patient's medical history and concomitant medications were not reported. Causal role of suspect vaccine is assessed as not related for type 1 diabetes, due to biological implausibility. For the event malaise, causality is assessed as not related due to implausible chronology.; Sender's Comments: A patient of an unknown age and gender was administered influenza virus vaccine polyvalent. The patient developed malaise, ten days after receiving vaccine. Another ten days after receiving influenza virus vaccine polyvalent symptoms of type 1 diabetes. The patient's medical history and concomitant medications were not reported. Causal role of suspect vaccine is assessed as not related for type 1 diabetes, due to biological implausibility. For the event malaise, causality is assessed as not related due to implausible chronology.
C/o aches, chills, headache and fever that began the next morning at 6:00 am  after receiving the vaccine. Treatment include  Advil.
Chills, achiness followed by extreme nausea and lack of appetite about 16 hours after injection. Nausea and loss of appetite lasted for 3 weeks. GFR declined from 58 to 37. Most recent GFR is 47. Based on doctor's recommendations, I will not be getting the 2nd dose of the vaccine.
Soreness in the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in the arm of injection) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness in the arm of injection). At the time of the report, VACCINATION SITE PAIN (Soreness in the arm of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt came in for vaccination 2/5/08. Ask all screening questions. Pt had no symptoms of flu. Pt was exposed to flu. Mom called pediatrician office and faxed in rx's for influenza vaccine. Mom took child to different office 2/6/08 and determined child had flu. Got Rx filled for Tamiflu. Explained to mother may be side effect not flu. Explained to mother flu vaccine would be de-activated. Pt had temperature, body aches.
It was reported that 15 months after immunization (Tdap) pt. collapsed and was taken to ER. Diagnosed with Vasovagal syncope and released on same day.
Patient developed fever following day after receiving vaccination at school, then  48 hours after vaccination, he developed vesicular rash on face near left ear and arms
13 year old patient rec'd Fluzone High Dose, no treatment necessary, no adverse reaction.
My period was due to start two days after getting the vaccine. I am very regular but after getting this vaccine my period was two weeks late. Pregnancy was the only other time my cycle was this off.
Shortly after on the 13th of April it seemed like I was being to get a cough which then turned into a loss of voice then my cough has persisted and it?s coupled w phlegm since the vaccine  at a dr visit on April 16th I mentioned it to my provider and she said there seem to be no infection might be laryngitis but it hasn?t resolved there?s no other symptoms
Patient had fever and chills for 2 days after the shot. Patient also had mouth ulcers since the shot was given. He went to the doctor for mabex solution.
66yo with HIV received ZOSTAVAX vaccine on 12/2/2010. Patient presented to the clinic on 12/20/10 with complaints of a painful rash (pain 10/10) over his right eye which he noted occurred on 12/14/10. The pain was also noted as a shooting pain. Red papules were noted over the right side of the scalp, forehead and eyelid dermatome like distribution. A viral swab obtained revealed positive for varicella zoster. Suspected medication: ZOSTAVAX vaccine live. Patient was treated with acyclovir.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2007, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) for routine adult health maintenance and for the long-term prevention of shingles.  The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In 2016, the patient was treated by a physician, for the onset of a severe vesicular rash which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Cramping with heavy menstrual bleeding for 8 days, followed by frequent spotting and sporadic bleeding, still continuing.
unresponsive, lethargic; vomiting of blood & blood in stool; dehydrated; to hosp for tx of intussusception-poss from Rotavirus vax;had the enema, didn't work;surgery;
41-year-old woman who presents to the office on 1/12/2021 for fatigue, congestion of nose and eyes and lack of taste and smell.  Patient's initial symptoms started on 1/8/2021 with some rhinorrhea.  The following day on 1/9/2021 she went to the gym feeling fine.  That evening she felt fatigued and attributed to her workout earlier in the day.  The next day she developed a severe headache with fever, sweats, chills and body aches.  Yesterday on 1/10/2021 she developed nasal congestion and eye symptoms.  Patient presented to the office today on 1/12/2021 for testing and was Covid positive.  Patient had a positive Covid test on 11/11/2020 with mild symptoms of headache, fatigue without congestion or loss of taste and smell.  At that time the duration of her symptoms was 3 days.  She had the first Pfizer Covid vaccine on 12/18/2020 with minimal muscle soreness.  She had the second Pfizer Covid vaccine on 1/8/2021.  Patient works in administration of a medical facility.  She has minimal contact with clinical staff and patients.  No one in her office has had Covid symptoms or infection.  Patient's other contacts are at home and the gym.  She does attend a gym class with 10 other participants.  She does not know whether anyone in the gym class has had symptoms.
pt recv vax 13OCT95 & JAN96 pt was exposed to wild-type varicella virus;28JAN96 pt devel chicken pox w/24 lesions on the second day;
Started having flu like symptoms of pain and body aches. A week like she started having uncontrollable high blood high pressure. She stated she lost 10lbs, nausea, headaches and chills & hot flashes.
Information has been received from a physician concerning a female inpatient with pneumonia and febrile who was vaccinated with pneumococcal vaccine 23 polyvalent, per hospital protocol. Subsequently the pt developed increased fever and respiratory symptoms. The outcome of the pt's increased fever and respiratory symptoms was not known. The physician reported that the pt's increased fever and respiratory symptoms prolonged the pt's hospitalization. Follow-up information received from a woman in the physician's office indicated that the office did not have any information on this patient, not even a date of birth. It was reported that the physician was probably a consulting physician on the case, and additional information would be difficult to obtain wihtout the patient's date of birth. No further information is available. Follow-up information received form the physician indicated that pneumonia occurred in the patient and she was given pneumococcal vaccine 23 polyvalent vaccine adn on 4/10/02, the pneumonia severely worsened after vaccination. He also reported that the patient had an increase in fever and an allergic reaction to the pneumococcal vaccine 23 polybalent. It was unknown if the patient recovered. The physician considered the event to be immediately life-threatening. Additional information is not expected.
Red sore arm approximately 4 inches below the injection site. Hot red circle diameter 3 to 4 inches. Throbbing sensation and itching sensation. Lasted 1 week after injection.
Patient and mother have not reported any symptoms associated with the administration of the vaccine. The patient came in for her 2nd dose Pfizer (monovalent) and the Pfizer (bivalent) vaccination was given instead
Patient received first dose of Pfizer vaccine and was waiting in the observation area when she fainted, fell from the chair, and hit her head. Patient was awakened with the ammonia inhalant. Patient tried to sit up and fainted a second time. Patient was assessed by an RN. Patient began to develop a hematoma to the left side of the forehead and some bruising to the left side of the face. Patient refused EMS and called her father to pick her up. Patient stated that feeling dizzy and fainting was a common occurrence after she received injections. Patient?s father arrived at 1500. Patient continued to refuse EMS, but both patient and her father were strongly advised to go to the ED to have her assessed further. Patient was helped to wheelchair and accompanied by security and RN to the car at 1507.
DAY 1: Needed help walking out after shot due to dizziness within 15 minutes. Could hardly raise shot arm wihin 45 minutes. Extremely tired within an hour. Cold and achy started overnight. DAY2: cold, extremely achy, headache, dizzy, weak. Fever increased throughout day. Peaked at 101.9F at 2:45pm. Sharp pain in lower left abdomen. Rumbly tummy. Pulse spiking high with no exertion. Resting heart rate in 120's (my normal is high 60's). Out of breath without any exertion. Lungs feel like they're on fire. Oxygen varied between 85%-95% (my normal is 99-100%). Confirmed by PulseOx. Drank water or gateraide every hour or two. No appetite, but forced myself to eat light foods. DAY 3: Improving a bit, but lungs feel raw.
pt recv vax 23SEP96 & 2OCT96 pt had lesions (25 lesions on trunk);parent called MD office 4OCT pt covered w/lesions;
The morning after receiving the flu shot, pt. states that her tongue felt numb and that her arm was double in size and was itching. States that on 10-23-13 her tongue is less numb and arm swelling was decreased.
pt exp lethargy 2 days p/recvd flu vax; 26OCT91 exp inc confusion & chest congstion w/a non productive cough; cough was also noted on 30OCT91 along w/elevation in temp;
Pt states immediately after receiving the vaccine her lips became numb. Pt denies any swelling, difficulty swallowing, rash, or hives. NP and EMT determined the pt is having anxiety. Pt refused vitals. After 30 minutes the pt stated she is feeling better and would like to leave. Pt didn?t require transport to hospital. NP referred pt to high risk clinic for second dose.
4/9 - Sore arm at injection site 4/10 - Sore arm, swollen lymph node in armpit of injection site, mild itching around injection site and in armpit of injection site 4/11 - continuation of symptoms from 4/10 4/12 - continuation of symptoms from 4/10, itching subsided 4/13 - Swollen lymph node in neck on side if injection site
1 of 2 pts vaxed from the same lot who exp an inj site rxn;pt devel redness & induration (no measurement taken);not seen in office-pt reported event 4FEB94;pt recovered;